Activities and mechanisms of action of halogen-substituted flavanoids against poliovirus type 2 infection in vitro.
The effects of some halogen-substituted flavanoids (dichloroflavan, halogenated isoflavans, and isoflavenes) on poliovirus type 2 infection was examined. Only two isoflavenes exhibited a significant inhibitory activity on the virus-induced cytopathic effect and plaque formation. In a single cycle of viral replication, both compounds reduced the viral yield by approximately 90%. The presence of the isoflavenes from the beginning of infection or during the adsorption period only prevented the shutoff of host translation and viral RNA and protein synthesis, suggesting that the drugs blocked an early step of viral replication. Indeed, both isoflavenes were not virucidal, did not protect virus infectivity from heat inactivation, and had no measurable effect on the binding of virus to cells, viral penetration, and uncoating of the viral RNA. In contrast, both compounds significantly reduced the infectivity of free viral RNA. The possibility that compounds interfere with poliovirus replication at a very early stage of translation of the input RNA is discussed.
Conti
C
C
Institute of Microbiology, University of Rome La Sapienza, Italy.
Genovese
D
D
Santoro
R
R
Stein
M L
ML
Orsi
N
N
Fiore
L
L
D005419:Flavonoids / Q000494:pharmacology*; D006219:Halogens / Q000494:pharmacology; D006801:Humans; D007529:Isoflavones / Q000494:pharmacology*; D017955:Poliovirus / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D012367:RNA, Viral / Q000096:biosynthesis / Q000235:genetics; D014178:Translocation, Genetic; D010948:Viral Plaque Assay; D014764:Viral Proteins / Q000096:biosynthesis; D014779:Virus Replication / Q000187:drug effects / Q000235:genetics
D005419:Flavonoids; D006219:Halogens; D007529:Isoflavones; D012367:RNA, Viral; D014764:Viral Proteins; C063932:3(2H)-isoflavene; C063933:6-chloro-3(2H)-isoflavene